# GO_molecular_function_0052: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/GO_molecular_function_0052.txt)

**Task:** `GO_molecular_function`  
**Author key, unchanged:** **B** — odorant binding

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | contradicted | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | contradicted | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MSFLFFLVVLISIGLWVGPCVADNPENRCIKQFAKTNPACIVHCKYNLYKFTDDNYDITDQHINKFTDVLIKNKAVDGSKKSQVQEHLKKCAEESLKKTHGKNCQRLVEYYSCAVDNKLIDYFKYESAINSYDRSIYTPPYSG

[Multiple Choices]
A. nicotinate-nucleotide adenylyltransferase activity
B. odorant binding
C. calmodulin binding
D. enzyme inhibitor activity
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: contradicted

> For this exact sequence, the record reports experimentally supported inhibition of host coagulation factor XII, which aligns with enzyme inhibitor activity (D). Odorant binding (B) appears only as an InterPro-based computational annotation, so the evidence weighs against B as the primary function.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [C7](#evidence-c7), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The N-terminal hydrophobic segment suggests secretion, and the cysteine-rich sequence is compatible with a small secreted protein; those features do not by themselves distinguish odorant binding from enzyme inhibition.


**Missing item-specific fact**

> The sequence-to-family annotation or experimentally characterized activity for this particular protein is needed to choose among these functions.


**Reason**

> No supplied context or general sequence feature meaningfully distinguishes the options. Identifying an insect odorant-binding-like family or recalling this protein's experimentally characterized inhibitory activity requires protein-specific knowledge not provided in the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "D"
]
```

> B has a computational InterPro-based annotation, while D is supported by experimental evidence. The evidence does not establish that odorant binding is impossible, but it supports D much more strongly as the primary function.


### Important caveats

- The exact-sequence match is to UniProt entry L0MZ37; the author’s source snapshot is unknown.
- The odorant-binding annotation is computational (IEA:InterPro), whereas the reported inhibitory function has experimental evidence.
- The cited evidence supports inhibition but does not directly test or rule out odorant binding.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The N-terminal hydrophobic segment suggests secretion, and the cysteine-rich sequence is compatible with a small secreted protein; those features do not by themselves distinguish odorant binding from enzyme inhibition.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The sequence-to-family annotation or experimentally characterized activity for this particular protein is needed to choose among these functions.",
    "reason": "No supplied context or general sequence feature meaningfully distinguishes the options. Identifying an insect odorant-binding-like family or recalling this protein's experimentally characterized inhibitory activity requires protein-specific knowledge not provided in the question."
  },
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "C7",
      "H3",
      "H4"
    ],
    "judgment": "contradicted",
    "reason": "For this exact sequence, the record reports experimentally supported inhibition of host coagulation factor XII, which aligns with enzyme inhibitor activity (D). Odorant binding (B) appears only as an InterPro-based computational annotation, so the evidence weighs against B as the primary function."
  },
  "important_caveats": [
    "The exact-sequence match is to UniProt entry L0MZ37; the author’s source snapshot is unknown.",
    "The odorant-binding annotation is computational (IEA:InterPro), whereas the reported inhibitory function has experimental evidence.",
    "The cited evidence supports inhibition but does not directly test or rule out odorant binding."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "D"
    ],
    "reason": "B has a computational InterPro-based annotation, while D is supported by experimental evidence. The evidence does not establish that odorant binding is impossible, but it supports D much more strongly as the primary function."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "judgment": "contradicted",
    "reason": "For this exact sequence, the record reports experimentally supported inhibition of host coagulation factor XII, which aligns with enzyme inhibitor activity (D). Odorant binding (B) appears only as an InterPro-based computational annotation, so the evidence weighs against B as the primary function.",
    "evidence_ids": ["C5", "C6", "C7", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The N-terminal hydrophobic segment suggests secretion, and the cysteine-rich sequence is compatible with a small secreted protein; those features do not by themselves distinguish odorant binding from enzyme inhibition.",
    "missing_item_specific_fact": "The sequence-to-family annotation or experimentally characterized activity for this particular protein is needed to choose among these functions.",
    "reason": "No supplied context or general sequence feature meaningfully distinguishes the options. Identifying an insect odorant-binding-like family or recalling this protein's experimentally characterized inhibitory activity requires protein-specific knowledge not provided in the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "D"],
    "reason": "B has a computational InterPro-based annotation, while D is supported by experimental evidence. The evidence does not establish that odorant binding is impossible, but it supports D much more strongly as the primary function."
  },
  "important_caveats": [
    "The exact-sequence match is to UniProt entry L0MZ37; the author’s source snapshot is unknown.",
    "The odorant-binding annotation is computational (IEA:InterPro), whereas the reported inhibitory function has experimental evidence.",
    "The cited evidence supports inhibition but does not directly test or rule out odorant binding."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> GO:0005549 (odorant binding) is annotated in UniProt entry L0MZ37 (evidence_id C6/H4). However, this annotation carries evidence code IEA:InterPro, meaning it is a purely computational inference from InterPro domain matching, not experimental evidence. The protein's experimentally validated molecular function (ECO:0000269, PubMed:35817195) is inhibition of coagulation factor XII activation, corresponding to GO:0090729 (toxin activity, IDA) and functionally to enzyme inhibitor activity (option D). The expected answer is technically present in the database but represents a low-confidence automated annotation that contradicts the experimentally determined function.

Citations as saved: [C6](#evidence-c6), [H4](#evidence-h4), [C5](#evidence-c5), [H3](#evidence-h3), [C7](#evidence-c7), [H5](#evidence-h5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains a signal peptide and a ~120-residue mature domain. Without database lookup, a model reasoning from sequence features would identify serpin-like or lipocalin-like structural motifs. The experimental literature (PubMed:35817195) establishes this protein as a coagulation factor XII inhibitor, making 'enzyme inhibitor activity' (D) the biologically accurate answer. The 'odorant binding' label arises solely from an InterPro domain-similarity call (IEA), not from any observable odorant-binding motif in the sequence. No general biological reasoning from the raw sequence would preferentially select 'odorant binding' over 'enzyme inhibitor activity'; in fact, the opposite is more defensible.


**Missing item-specific fact**

> The specific InterPro domain assignment that triggers the IEA:InterPro annotation of GO:0005549 for this exact sequence, and the knowledge that the benchmark authors used the database annotation (including low-confidence IEA entries) as the ground truth rather than the experimentally validated function.


**Reason**

> Selecting 'odorant binding' over 'enzyme inhibitor activity' requires knowing that this particular sequence received an automated InterPro-based odorant-binding annotation in UniProt, despite its experimentally confirmed role as a serpin-type coagulation inhibitor. No sequence-level reasoning independently justifies 'odorant binding' over the other options; the answer depends entirely on matching the protein to its specific database annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "D"
]
```

> Option B (odorant binding) is the database IEA annotation. Option D (enzyme inhibitor activity, GO:0004857) is directly supported by experimental evidence (the protein inhibits factor XII activation). Both are defensible GO molecular function annotations for this protein. The question wording ('primary molecular function') arguably favors D, since the experimentally characterized primary activity is inhibition of F12, while odorant binding is an automated fold-similarity call with no functional validation.


### Important caveats

- The GO:0005549 annotation is IEA:InterPro (automated), not experimental. The experimentally validated function (ECO:0000269, IDA) is toxin activity / coagulation inhibition, not odorant binding.
- The author's expected answer matches a low-confidence computational annotation while contradicting the primary experimental evidence in the same database entry.
- The identity of the protein (L0MZ37, Ayaconin) was inferred from image-path metadata absent from the model input; the model sees only a 143-residue sequence.
- The benchmark's ground-truth construction methodology (whether it selects IEA annotations or only curated/experimental annotations) is unknown and affects whether this question tests prediction or annotation retrieval.
- The protein is a serpin-like coagulation pathway inhibitor from a sand fly; 'odorant binding' is likely a false-positive fold-similarity call by InterPro.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a signal peptide and a ~120-residue mature domain. Without database lookup, a model reasoning from sequence features would identify serpin-like or lipocalin-like structural motifs. The experimental literature (PubMed:35817195) establishes this protein as a coagulation factor XII inhibitor, making 'enzyme inhibitor activity' (D) the biologically accurate answer. The 'odorant binding' label arises solely from an InterPro domain-similarity call (IEA), not from any observable odorant-binding motif in the sequence. No general biological reasoning from the raw sequence would preferentially select 'odorant binding' over 'enzyme inhibitor activity'; in fact, the opposite is more defensible.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific InterPro domain assignment that triggers the IEA:InterPro annotation of GO:0005549 for this exact sequence, and the knowledge that the benchmark authors used the database annotation (including low-confidence IEA entries) as the ground truth rather than the experimentally validated function.",
    "reason": "Selecting 'odorant binding' over 'enzyme inhibitor activity' requires knowing that this particular sequence received an automated InterPro-based odorant-binding annotation in UniProt, despite its experimentally confirmed role as a serpin-type coagulation inhibitor. No sequence-level reasoning independently justifies 'odorant binding' over the other options; the answer depends entirely on matching the protein to its specific database annotation."
  },
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "evidence_ids": [
      "C6",
      "H4",
      "C5",
      "H3",
      "C7",
      "H5"
    ],
    "judgment": "supported",
    "reason": "GO:0005549 (odorant binding) is annotated in UniProt entry L0MZ37 (evidence_id C6/H4). However, this annotation carries evidence code IEA:InterPro, meaning it is a purely computational inference from InterPro domain matching, not experimental evidence. The protein's experimentally validated molecular function (ECO:0000269, PubMed:35817195) is inhibition of coagulation factor XII activation, corresponding to GO:0090729 (toxin activity, IDA) and functionally to enzyme inhibitor activity (option D). The expected answer is technically present in the database but represents a low-confidence automated annotation that contradicts the experimentally determined function."
  },
  "important_caveats": [
    "The GO:0005549 annotation is IEA:InterPro (automated), not experimental. The experimentally validated function (ECO:0000269, IDA) is toxin activity / coagulation inhibition, not odorant binding.",
    "The author's expected answer matches a low-confidence computational annotation while contradicting the primary experimental evidence in the same database entry.",
    "The identity of the protein (L0MZ37, Ayaconin) was inferred from image-path metadata absent from the model input; the model sees only a 143-residue sequence.",
    "The benchmark's ground-truth construction methodology (whether it selects IEA annotations or only curated/experimental annotations) is unknown and affects whether this question tests prediction or annotation retrieval.",
    "The protein is a serpin-like coagulation pathway inhibitor from a sand fly; 'odorant binding' is likely a false-positive fold-similarity call by InterPro."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "D"
    ],
    "reason": "Option B (odorant binding) is the database IEA annotation. Option D (enzyme inhibitor activity, GO:0004857) is directly supported by experimental evidence (the protein inhibits factor XII activation). Both are defensible GO molecular function annotations for this protein. The question wording ('primary molecular function') arguably favors D, since the experimentally characterized primary activity is inhibition of F12, while odorant binding is an automated fold-similarity call with no functional validation."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "GO:0005549 (odorant binding) is annotated in UniProt entry L0MZ37 (evidence_id C6/H4). However, this annotation carries evidence code IEA:InterPro, meaning it is a purely computational inference from InterPro domain matching, not experimental evidence. The protein's experimentally validated molecular function (ECO:0000269, PubMed:35817195) is inhibition of coagulation factor XII activation, corresponding to GO:0090729 (toxin activity, IDA) and functionally to enzyme inhibitor activity (option D). The expected answer is technically present in the database but represents a low-confidence automated annotation that contradicts the experimentally determined function.",
    "evidence_ids": ["C6", "H4", "C5", "H3", "C7", "H5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains a signal peptide and a ~120-residue mature domain. Without database lookup, a model reasoning from sequence features would identify serpin-like or lipocalin-like structural motifs. The experimental literature (PubMed:35817195) establishes this protein as a coagulation factor XII inhibitor, making 'enzyme inhibitor activity' (D) the biologically accurate answer. The 'odorant binding' label arises solely from an InterPro domain-similarity call (IEA), not from any observable odorant-binding motif in the sequence. No general biological reasoning from the raw sequence would preferentially select 'odorant binding' over 'enzyme inhibitor activity'; in fact, the opposite is more defensible.",
    "missing_item_specific_fact": "The specific InterPro domain assignment that triggers the IEA:InterPro annotation of GO:0005549 for this exact sequence, and the knowledge that the benchmark authors used the database annotation (including low-confidence IEA entries) as the ground truth rather than the experimentally validated function.",
    "reason": "Selecting 'odorant binding' over 'enzyme inhibitor activity' requires knowing that this particular sequence received an automated InterPro-based odorant-binding annotation in UniProt, despite its experimentally confirmed role as a serpin-type coagulation inhibitor. No sequence-level reasoning independently justifies 'odorant binding' over the other options; the answer depends entirely on matching the protein to its specific database annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "D"],
    "reason": "Option B (odorant binding) is the database IEA annotation. Option D (enzyme inhibitor activity, GO:0004857) is directly supported by experimental evidence (the protein inhibits factor XII activation). Both are defensible GO molecular function annotations for this protein. The question wording ('primary molecular function') arguably favors D, since the experimentally characterized primary activity is inhibition of F12, while odorant binding is an automated fold-similarity call with no functional validation."
  },
  "important_caveats": [
    "The GO:0005549 annotation is IEA:InterPro (automated), not experimental. The experimentally validated function (ECO:0000269, IDA) is toxin activity / coagulation inhibition, not odorant binding.",
    "The author's expected answer matches a low-confidence computational annotation while contradicting the primary experimental evidence in the same database entry.",
    "The identity of the protein (L0MZ37, Ayaconin) was inferred from image-path metadata absent from the model input; the model sees only a 143-residue sequence.",
    "The benchmark's ground-truth construction methodology (whether it selects IEA annotations or only curated/experimental annotations) is unknown and affects whether this question tests prediction or annotation retrieval.",
    "The protein is a serpin-like coagulation pathway inhibitor from a sand fly; 'odorant binding' is likely a false-positive fold-similarity call by InterPro."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: contradicted

> The sequence-matched record reports experimentally supported inhibition of factor XII activation, which fits enzyme inhibitor activity (D) better as the primary function than odorant binding (B). The odorant-binding annotation is computationally assigned by InterPro, not experimental evidence of odorant binding.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence begins with a hydrophobic signal peptide and encodes a small, cysteine-rich secreted protein, a pattern seen in insect odorant-binding-protein families. That family-level resemblance gives a transferable, probabilistic basis for choosing B over the unrelated metabolic-enzyme and calmodulin-binding options. It does not establish odorant binding as this protein’s primary function, and secreted proteins can have other activities.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A meaningful family-level inference toward B is available from the original sequence and choices, so the distinction does not require recalling this exact protein’s record. The inference is limited: sequence-family resemblance does not rule out a different or additional activity.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer evidence supports factor XII inhibition experimentally, whereas the odorant-binding term is only computationally assigned; the evidence does not establish odorant binding as a second primary function.


### Important caveats

- The family-level sequence inference supports a prediction, not a verified ligand-binding activity.
- The experimental function evidence and the computational GO annotation differ in evidential strength.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence begins with a hydrophobic signal peptide and encodes a small, cysteine-rich secreted protein, a pattern seen in insect odorant-binding-protein families. That family-level resemblance gives a transferable, probabilistic basis for choosing B over the unrelated metabolic-enzyme and calmodulin-binding options. It does not establish odorant binding as this protein’s primary function, and secreted proteins can have other activities.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A meaningful family-level inference toward B is available from the original sequence and choices, so the distinction does not require recalling this exact protein’s record. The inference is limited: sequence-family resemblance does not rule out a different or additional activity."
  },
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6"
    ],
    "judgment": "contradicted",
    "reason": "The sequence-matched record reports experimentally supported inhibition of factor XII activation, which fits enzyme inhibitor activity (D) better as the primary function than odorant binding (B). The odorant-binding annotation is computationally assigned by InterPro, not experimental evidence of odorant binding."
  },
  "important_caveats": [
    "The family-level sequence inference supports a prediction, not a verified ligand-binding activity.",
    "The experimental function evidence and the computational GO annotation differ in evidential strength."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports factor XII inhibition experimentally, whereas the odorant-binding term is only computationally assigned; the evidence does not establish odorant binding as a second primary function."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "judgment": "contradicted",
    "reason": "The sequence-matched record reports experimentally supported inhibition of factor XII activation, which fits enzyme inhibitor activity (D) better as the primary function than odorant binding (B). The odorant-binding annotation is computationally assigned by InterPro, not experimental evidence of odorant binding.",
    "evidence_ids": ["C5", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence begins with a hydrophobic signal peptide and encodes a small, cysteine-rich secreted protein, a pattern seen in insect odorant-binding-protein families. That family-level resemblance gives a transferable, probabilistic basis for choosing B over the unrelated metabolic-enzyme and calmodulin-binding options. It does not establish odorant binding as this protein’s primary function, and secreted proteins can have other activities.",
    "missing_item_specific_fact": "",
    "reason": "A meaningful family-level inference toward B is available from the original sequence and choices, so the distinction does not require recalling this exact protein’s record. The inference is limited: sequence-family resemblance does not rule out a different or additional activity."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports factor XII inhibition experimentally, whereas the odorant-binding term is only computationally assigned; the evidence does not establish odorant binding as a second primary function."
  },
  "important_caveats": [
    "The family-level sequence inference supports a prediction, not a verified ligand-binding activity.",
    "The experimental function evidence and the computational GO annotation differ in evidential strength."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry L0MZ37 carries a GO:0005549 'odorant binding' annotation (evidence C6/H4) with evidence code IEA:InterPro, meaning it is a computational domain-match inference rather than experimental data. The annotation is present and matches option B textually. However, the experimentally determined function (ECO:0000269, IDA evidence, C5/H3/C7/H5) is inhibition of coagulation factor XII, which aligns with option D (enzyme inhibitor activity) and GO:0090729 toxin activity. The 'odorant binding' key is supported only by an automated InterPro domain annotation, not by experimental evidence; the experimental evidence actually points to a different molecular function.

Citations as saved: [C6](#evidence-c6), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 143-residue sequence contains a hydrophobic N-terminal signal peptide and a cysteine-rich pattern (8 Cys residues) in a small, disulfide-stabilized scaffold, which are hallmark features of the insect odorant-binding protein (OBP) superfamily. Insect OBPs are typically 120-150 aa, secreted (signal peptide), and stabilized by a conserved cysteine motif. Recognizing this fold from other insect OBPs (e.g., Bombyx mori PBP, Drosophila OBP1a) provides a family-level inference favoring B over A (nicotinate-nucleotide adenylyltransferase: a ~200-aa catalytic transferase with distinct Rossmann-like motifs absent here), C (calmodulin binding: requires amphipathic helical IQ-like motifs not present), and D (enzyme inhibitor activity: while some OBP-fold proteins are inhibitors, the classic OBP domain architecture without additional inhibitor-specific loops or reactive-site motifs would lead a fold-recognition-based model to choose B). The OBP fold recognition is transferable knowledge from the broader insect OBP family.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A model recognizing the small size, signal peptide, and cysteine-stabilized fold as consistent with the insect OBP superfamily can meaningfully distinguish B from A and C. The distinction from D is less clean because some arthropod salivary proteins repurpose the OBP fold for enzyme inhibition, but the absence of a canonical reactive-site loop or serpin/Kunitz-type inhibitor architecture still favors B as the fold-based prediction. This is a defensible family-level inference, not a lookup of this specific protein's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "D"
]
```

> The OBP-like fold is shared by true odorant-binding proteins and by arthropod salivary enzyme inhibitors (a well-documented evolutionary co-option). From sequence alone, B is favored by fold recognition, but D is the experimentally verified function. A knowledgeable model aware of the OBP-fold versatility in insect salivary glands could argue for D. The IEA:InterPro annotation supports B computationally while the IDA/ECO:0000269 evidence supports D experimentally.


### Important caveats

- The 'odorant binding' annotation is IEA:InterPro (computational domain match), not experimental evidence. The experimentally verified function (PubMed:35817195, ECO:0000269) is inhibition of coagulation factor XII, consistent with option D.
- The protein is a sand fly salivary protein (Ayaconin/LayS37); many arthropod salivary proteins share the OBP fold but function as enzyme inhibitors rather than odorant carriers.
- The sequence contains 8 cysteines rather than the canonical 6 of classical insect OBPs, making the OBP fold assignment somewhat atypical.
- The reviewer-only UniProt accession and organism identity were not available to the evaluated model; the fold-based reasoning must rely solely on sequence features and general protein-family knowledge.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 143-residue sequence contains a hydrophobic N-terminal signal peptide and a cysteine-rich pattern (8 Cys residues) in a small, disulfide-stabilized scaffold, which are hallmark features of the insect odorant-binding protein (OBP) superfamily. Insect OBPs are typically 120-150 aa, secreted (signal peptide), and stabilized by a conserved cysteine motif. Recognizing this fold from other insect OBPs (e.g., Bombyx mori PBP, Drosophila OBP1a) provides a family-level inference favoring B over A (nicotinate-nucleotide adenylyltransferase: a ~200-aa catalytic transferase with distinct Rossmann-like motifs absent here), C (calmodulin binding: requires amphipathic helical IQ-like motifs not present), and D (enzyme inhibitor activity: while some OBP-fold proteins are inhibitors, the classic OBP domain architecture without additional inhibitor-specific loops or reactive-site motifs would lead a fold-recognition-based model to choose B). The OBP fold recognition is transferable knowledge from the broader insect OBP family.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A model recognizing the small size, signal peptide, and cysteine-stabilized fold as consistent with the insect OBP superfamily can meaningfully distinguish B from A and C. The distinction from D is less clean because some arthropod salivary proteins repurpose the OBP fold for enzyme inhibition, but the absence of a canonical reactive-site loop or serpin/Kunitz-type inhibitor architecture still favors B as the fold-based prediction. This is a defensible family-level inference, not a lookup of this specific protein's annotation."
  },
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "evidence_ids": [
      "C6",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry L0MZ37 carries a GO:0005549 'odorant binding' annotation (evidence C6/H4) with evidence code IEA:InterPro, meaning it is a computational domain-match inference rather than experimental data. The annotation is present and matches option B textually. However, the experimentally determined function (ECO:0000269, IDA evidence, C5/H3/C7/H5) is inhibition of coagulation factor XII, which aligns with option D (enzyme inhibitor activity) and GO:0090729 toxin activity. The 'odorant binding' key is supported only by an automated InterPro domain annotation, not by experimental evidence; the experimental evidence actually points to a different molecular function."
  },
  "important_caveats": [
    "The 'odorant binding' annotation is IEA:InterPro (computational domain match), not experimental evidence. The experimentally verified function (PubMed:35817195, ECO:0000269) is inhibition of coagulation factor XII, consistent with option D.",
    "The protein is a sand fly salivary protein (Ayaconin/LayS37); many arthropod salivary proteins share the OBP fold but function as enzyme inhibitors rather than odorant carriers.",
    "The sequence contains 8 cysteines rather than the canonical 6 of classical insect OBPs, making the OBP fold assignment somewhat atypical.",
    "The reviewer-only UniProt accession and organism identity were not available to the evaluated model; the fold-based reasoning must rely solely on sequence features and general protein-family knowledge."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "D"
    ],
    "reason": "The OBP-like fold is shared by true odorant-binding proteins and by arthropod salivary enzyme inhibitors (a well-documented evolutionary co-option). From sequence alone, B is favored by fold recognition, but D is the experimentally verified function. A knowledgeable model aware of the OBP-fold versatility in insect salivary glands could argue for D. The IEA:InterPro annotation supports B computationally while the IDA/ECO:0000269 evidence supports D experimentally."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0052",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry L0MZ37 carries a GO:0005549 'odorant binding' annotation (evidence C6/H4) with evidence code IEA:InterPro, meaning it is a computational domain-match inference rather than experimental data. The annotation is present and matches option B textually. However, the experimentally determined function (ECO:0000269, IDA evidence, C5/H3/C7/H5) is inhibition of coagulation factor XII, which aligns with option D (enzyme inhibitor activity) and GO:0090729 toxin activity. The 'odorant binding' key is supported only by an automated InterPro domain annotation, not by experimental evidence; the experimental evidence actually points to a different molecular function.",
    "evidence_ids": ["C6", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 143-residue sequence contains a hydrophobic N-terminal signal peptide and a cysteine-rich pattern (8 Cys residues) in a small, disulfide-stabilized scaffold, which are hallmark features of the insect odorant-binding protein (OBP) superfamily. Insect OBPs are typically 120-150 aa, secreted (signal peptide), and stabilized by a conserved cysteine motif. Recognizing this fold from other insect OBPs (e.g., Bombyx mori PBP, Drosophila OBP1a) provides a family-level inference favoring B over A (nicotinate-nucleotide adenylyltransferase: a ~200-aa catalytic transferase with distinct Rossmann-like motifs absent here), C (calmodulin binding: requires amphipathic helical IQ-like motifs not present), and D (enzyme inhibitor activity: while some OBP-fold proteins are inhibitors, the classic OBP domain architecture without additional inhibitor-specific loops or reactive-site motifs would lead a fold-recognition-based model to choose B). The OBP fold recognition is transferable knowledge from the broader insect OBP family.",
    "missing_item_specific_fact": "",
    "reason": "A model recognizing the small size, signal peptide, and cysteine-stabilized fold as consistent with the insect OBP superfamily can meaningfully distinguish B from A and C. The distinction from D is less clean because some arthropod salivary proteins repurpose the OBP fold for enzyme inhibition, but the absence of a canonical reactive-site loop or serpin/Kunitz-type inhibitor architecture still favors B as the fold-based prediction. This is a defensible family-level inference, not a lookup of this specific protein's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "D"],
    "reason": "The OBP-like fold is shared by true odorant-binding proteins and by arthropod salivary enzyme inhibitors (a well-documented evolutionary co-option). From sequence alone, B is favored by fold recognition, but D is the experimentally verified function. A knowledgeable model aware of the OBP-fold versatility in insect salivary glands could argue for D. The IEA:InterPro annotation supports B computationally while the IDA/ECO:0000269 evidence supports D experimentally."
  },
  "important_caveats": [
    "The 'odorant binding' annotation is IEA:InterPro (computational domain match), not experimental evidence. The experimentally verified function (PubMed:35817195, ECO:0000269) is inhibition of coagulation factor XII, consistent with option D.",
    "The protein is a sand fly salivary protein (Ayaconin/LayS37); many arthropod salivary proteins share the OBP fold but function as enzyme inhibitors rather than odorant carriers.",
    "The sequence contains 8 cysteines rather than the canonical 6 of classical insect OBPs, making the OBP fold assignment somewhat atypical.",
    "The reviewer-only UniProt accession and organism identity were not available to the evaluated model; the fold-based reasoning must rely solely on sequence features and general protein-family knowledge."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

### Source check 1

**Check:** `mixed_annotations_require_qualification`.

> C5/H3 describe blocking host factor-XII activation with ECO:0000269; C6/H4 carry odorant binding as IEA:InterPro, and C7 carries toxin activity IDA.

**Remaining uncertainty:** These sources support the stated biological inhibition role; assigning the alternative enzyme-inhibitor option and excluding odorant binding require interpretation beyond citation presence, and dual functions are not ruled out.

Evidence checked: [C5](#evidence-c5), [C6](#evidence-c6), [C7](#evidence-c7), [H3](#evidence-h3), [H4](#evidence-h4).

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "L0MZ37",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "f48b94d6f355bf8e5650f2c39faa975bca6e218bfc3f31517d3877bb6c667b4d",
  "benchmark_sequence_length": 143,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 25,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2013-03-06",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a",
  "current_source_sequence_sha256": "f48b94d6f355bf8e5650f2c39faa975bca6e218bfc3f31517d3877bb6c667b4d",
  "current_source_sequence_length": 143,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 24,
  "selected_historical_version": {
    "accession": "L0MZ37",
    "database": "Swiss-Prot",
    "entryVersion": 24,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "SP15_LUTAY",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "d1e2af1800cc2394abd934a722dd73d429c29b573094e02cbd288087e7153333",
  "selected_historical_source_sequence_sha256": "f48b94d6f355bf8e5650f2c39faa975bca6e218bfc3f31517d3877bb6c667b4d",
  "selected_historical_source_sequence_length": 143,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 24,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/L0MZ37.json",
  "source_sha256": "e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a",
  "retrieved_utc": "2026-11-02T04:28:59.157851+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"L0MZ37\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/L0MZ37.json",
  "source_sha256": "e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a",
  "retrieved_utc": "2026-11-02T04:28:59.157851+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":25,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2013-03-06\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/L0MZ37.json",
  "source_sha256": "e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a",
  "retrieved_utc": "2026-11-02T04:28:59.157851+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Sand fly\",\"lineage\":[\"Eukaryota\",\"Metazoa\",\"Ecdysozoa\",\"Arthropoda\",\"Altocrustacea\",\"Allotriocarida\",\"Hexapoda\",\"Insecta\",\"Pterygota\",\"Neoptera\",\"Eumetabola\",\"Endopterygota\",\"Aparaglossata\",\"Panorpida\",\"Diptera\",\"Nematocera\",\"Psychodoidea\",\"Psychodidae\",\"Lutzomyia\",\"Helcocyrtomyia\"],\"scientificName\":\"Lutzomyia ayacuchensis\",\"taxonId\":252632}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/L0MZ37.json",
  "source_sha256": "e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a",
  "retrieved_utc": "2026-11-02T04:28:59.157851+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"35817195\",\"source\":\"PubMed\"}],\"value\":\"LayS37\"}}],\"flag\":\"Precursor\",\"recommendedName\":{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"35817195\",\"source\":\"PubMed\"}],\"value\":\"Ayaconin\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/L0MZ37.json",
  "source_sha256": "e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a",
  "retrieved_utc": "2026-11-02T04:28:59.157851+00:00",
  "json_pointer": "/comments/0",
  "excerpt": "{\"commentType\":\"FUNCTION\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"35817195\",\"source\":\"PubMed\"}],\"value\":\"Inhibits the intrinsic blood coagulation pathway in the host by blocking activation of host coagulation factor XII (F12)\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/L0MZ37.json",
  "source_sha256": "e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a",
  "retrieved_utc": "2026-11-02T04:28:59.157851+00:00",
  "json_pointer": "/uniProtKBCrossReferences/8",
  "excerpt": "{\"database\":\"GO\",\"id\":\"GO:0005549\",\"properties\":[{\"key\":\"GoTerm\",\"value\":\"F:odorant binding\"},{\"key\":\"GoEvidenceType\",\"value\":\"IEA:InterPro\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/L0MZ37.json",
  "source_sha256": "e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a",
  "retrieved_utc": "2026-11-02T04:28:59.157851+00:00",
  "json_pointer": "/uniProtKBCrossReferences/9",
  "excerpt": "{\"database\":\"GO\",\"evidences\":[{\"evidenceCode\":\"ECO:0000314\",\"id\":\"35817195\",\"source\":\"PubMed\"}],\"id\":\"GO:0090729\",\"properties\":[{\"key\":\"GoTerm\",\"value\":\"F:toxin activity\"},{\"key\":\"GoEvidenceType\",\"value\":\"IDA:UniProtKB\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C8

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/L0MZ37.json)

```json
{
  "evidence_id": "C8",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/L0MZ37.json",
  "source_sha256": "e78c28c6e536e738f6d7b1eb5713d8f3bf3f0d3a564bf91f42ee8591e249894a",
  "retrieved_utc": "2026-11-02T04:28:59.157851+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Kawahori S.\",\"Seki C.\",\"Mizushima D.\",\"Tabbabi A.\",\"Yamamoto D.S.\",\"Kato H.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"35817195\"},{\"database\":\"DOI\",\"id\":\"10.1016/j.actatropica.2022.106602\"}],\"citationType\":\"journal article\",\"firstPage\":\"106602\",\"id\":\"35817195\",\"journal\":\"Acta Trop.\",\"lastPage\":\"106602\",\"publicationDate\":\"2022\",\"title\":\"Ayaconin, a novel inhibitor of the plasma contact system from the sand fly Lutzomyia ayacuchensis, a vector of Andean-type cutaneous leishmaniasis.\",\"volume\":\"234\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"INTERACTION WITH HUMAN F12\",\"TISSUE SPECIFICITY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24",
  "source_sha256": "d1e2af1800cc2394abd934a722dd73d429c29b573094e02cbd288087e7153333",
  "retrieved_utc": "2026-11-02T04:29:01.937579+00:00",
  "source_locator": "lines 1-13",
  "excerpt": "ID   SP15_LUTAY              Reviewed;         143 AA.\nAC   L0MZ37; L0MXR4; L0MYF4; L0MZS7;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   06-MAR-2013, sequence version 1.\nDT   28-JAN-2026, entry version 24.\nDE   RecName: Full=Ayaconin {ECO:0000303|PubMed:35817195};\nDE   AltName: Full=LayS37 {ECO:0000303|PubMed:35817195};\nDE   Flags: Precursor;\nOS   Lutzomyia ayacuchensis (Sand fly).\nOC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;\nOC   Neoptera; Endopterygota; Diptera; Nematocera; Psychodoidea; Psychodidae;\nOC   Lutzomyia; Helcocyrtomyia.\nOX   NCBI_TaxID=252632;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 24,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24",
  "source_sha256": "d1e2af1800cc2394abd934a722dd73d429c29b573094e02cbd288087e7153333",
  "retrieved_utc": "2026-11-02T04:29:01.937579+00:00",
  "source_locator": "lines 23-29",
  "excerpt": "RN   [2] {ECO:0000305}\nRP   FUNCTION, INTERACTION WITH HUMAN F12, AND TISSUE SPECIFICITY.\nRX   PubMed=35817195; DOI=10.1016/j.actatropica.2022.106602;\nRA   Kawahori S., Seki C., Mizushima D., Tabbabi A., Yamamoto D.S., Kato H.;\nRT   \"Ayaconin, a novel inhibitor of the plasma contact system from the sand fly\nRT   Lutzomyia ayacuchensis, a vector of Andean-type cutaneous leishmaniasis.\";\nRL   Acta Trop. 234:106602-106602(2022).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 24,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24",
  "source_sha256": "d1e2af1800cc2394abd934a722dd73d429c29b573094e02cbd288087e7153333",
  "retrieved_utc": "2026-11-02T04:29:01.937579+00:00",
  "source_locator": "lines 30-32",
  "excerpt": "CC   -!- FUNCTION: Inhibits the intrinsic blood coagulation pathway in the host\nCC       by blocking activation of host coagulation factor XII (F12).\nCC       {ECO:0000269|PubMed:35817195}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 24,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24",
  "source_sha256": "d1e2af1800cc2394abd934a722dd73d429c29b573094e02cbd288087e7153333",
  "retrieved_utc": "2026-11-02T04:29:01.937579+00:00",
  "source_locator": "lines 50-50",
  "excerpt": "DR   GO; GO:0005549; F:odorant binding; IEA:InterPro.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 24,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24)

```json
{
  "evidence_id": "H5",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/L0MZ37?format=txt&versions=24",
  "source_sha256": "d1e2af1800cc2394abd934a722dd73d429c29b573094e02cbd288087e7153333",
  "retrieved_utc": "2026-11-02T04:29:01.937579+00:00",
  "source_locator": "lines 51-51",
  "excerpt": "DR   GO; GO:0090729; F:toxin activity; IDA:UniProtKB.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 24,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence GO1

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO1",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 43770-43794",
  "excerpt": "[Term]\nid: GO:0004515\nname: nicotinate-nucleotide adenylyltransferase activity\nnamespace: molecular_function\ndef: \"Catalysis of the reaction: nicotinate beta-D-ribonucleotide + ATP + H+ = deamido-NAD+ + diphosphate.\" [RHEA:22860]\nsynonym: \"ATP:nicotinate-nucleotide adenylyltransferase activity\" EXACT []\nsynonym: \"ATP:nicotinate-ribonucleotide adenylyltransferase activity\" RELATED [EC:2.7.7.18]\nsynonym: \"deamido-NAD(+) diphosphorylase activity\" RELATED [EC:2.7.7.18]\nsynonym: \"deamido-NAD(+) pyrophosphorylase activity\" RELATED [EC:2.7.7.18]\nsynonym: \"deamido-NAD+ pyrophosphorylase activity\" RELATED [EC:2.7.7.18]\nsynonym: \"deamidonicotinamide adenine dinucleotide pyrophosphorylase activity\" RELATED [EC:2.7.7.18]\nsynonym: \"NaMN-ATase activity\" RELATED [EC:2.7.7.18]\nsynonym: \"nicotinate mononucleotide adenylyltransferase activity\" RELATED [EC:2.7.7.18]\nsynonym: \"nicotinic acid mononucleotide adenylyltransferase\" NARROW []\nxref: EC:2.7.7.18\nxref: MetaCyc:NICONUCADENYLYLTRAN-RXN\nxref: Reactome:R-HSA-197235 \"NMNAT2 transfers an adenylyl group from ATP to NAMN to yield NAAD\"\nxref: Reactome:R-HSA-200474 \"NMNAT3 transfers an adenylyl group from ATP to NAMN to yield NAAD\"\nxref: Reactome:R-HSA-200512 \"NMNAT1 transfers an adenylyl group from ATP to NAMN to yield NAAD\"\nxref: RHEA:22860\nis_a: GO:0070566 ! adenylyltransferase activity\nproperty_value: skos:exactMatch EC:2.7.7.18\nproperty_value: skos:exactMatch MetaCyc:NICONUCADENYLYLTRAN-RXN\nproperty_value: skos:exactMatch RHEA:22860\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0004515"
}
```

### Evidence GO2

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO2",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 51487-51499",
  "excerpt": "[Term]\nid: GO:0004857\nname: enzyme inhibitor activity\nnamespace: molecular_function\nalt_id: GO:0048551\ndef: \"A molecular function regulator that reduces a catalytic activity.\" [GOC:ai, GOC:ebc]\ncomment: This term should only be used in cases when the regulator directly interacts with the enzyme, but does not result in a covalent modification.\nsynonym: \"metalloenzyme inhibitor activity\" NARROW []\nxref: Reactome:R-HSA-1474158 \"GCHFR binds to GCH1 and negatively regulates its activity\"\nxref: Reactome:R-HSA-1614336 \"SUMF2 binds SUMF1, inhibiting SUMF1-mediated activation of arylsulfatases\"\nis_a: GO:0030234 ! enzyme regulator activity\nis_a: GO:0140678 ! molecular function inhibitor activity\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0004857"
}
```

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO3",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 56977-56985",
  "excerpt": "[Term]\nid: GO:0005516\nname: calmodulin binding\nnamespace: molecular_function\ndef: \"Binding to calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states.\" [GOC:krc]\nsubset: goslim_chembl\nxref: Reactome:R-HSA-202110 \"eNOS:Caveolin-1 complex binds to CaM\"\nis_a: GO:0005515 ! protein binding\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0005516"
}
```

### Evidence GO4

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO4",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 57250-57257",
  "excerpt": "[Term]\nid: GO:0005549\nname: odorant binding\nnamespace: molecular_function\ndef: \"Binding to an odorant, any substance capable of stimulating the sense of smell.\" [GOC:jl, ISBN:0721662544]\nsubset: goslim_pir\nis_a: GO:0005488 ! binding\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0005549"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json), zero-based source row 52. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
